Risk-Adjusted Returns: Emerging Market ETFs vs. US Small-Cap Value Funds (10-Year Horizon)

The Core Analytical Framework

Before diving into conclusions, two honest admissions are warranted: (1) 10-year return forecasts carry wide confidence intervals regardless of who makes them, and (2) these are meaningfully different risk profiles—not just different return expectations—which matters for how you interpret every metric that follows.

The right comparison metric is Sharpe ratio (excess return over risk-free rate ÷ volatility), not raw returns. Both asset classes are high-volatility; the question is whether you're being adequately compensated for the risk you're absorbing.

---

Historical Baseline: What the Data Actually Shows

The historical verdict is unambiguous: US small-cap value has delivered roughly 2–3x better risk-adjusted returns over the past decade. However, this period overlapped with an extraordinary run for US large-cap growth and a persistently strong dollar—two conditions that structurally suppressed EM returns. Extrapolating this forward without adjustment would be recency bias.

---

Current Macroeconomic Conditions: The Relevant Factors

Headwinds Facing Emerging Markets

Dollar strength and debt dynamics. EM assets have a well-documented inverse relationship with USD strength. Dollar-denominated debt becomes more expensive; capital flows toward higher-yielding US assets. While the Fed appears to be in a rate-cutting cycle, the pace and depth of dollar weakening remains uncertain—and EM has already absorbed years of outflows.

The China problem—which deserves its own discussion. China represents ~25–30% of major EM indices (VWO, EEM, IEMG), and its outlook is structurally challenging: property sector deflation, peak working-age population (peaked 2022), escalating US-China decoupling risk, and demonstrably unpredictable regulatory behavior (the 2021 tech crackdown wiped out hundreds of billions in market cap overnight). Any EM analysis that doesn't explicitly take a position on China is incomplete. This single factor substantially undermines the "cheap valuations" argument for broad EM indices.

Geopolitical tail risk. A Taiwan conflict scenario—however low probability—would catastrophically affect EM indices while only moderately affecting US small-cap value. This asymmetric tail risk is real and poorly captured by standard volatility metrics.

Tailwinds Facing Emerging Markets

Valuation differential. This is the strongest objective argument for EM. MSCI EM trades at approximately 11–13x forward P/E versus 13–16x for US small-cap value. On CAPE measures, EM sits near historical lows relative to US equities. Academic research (Asness, Research Affiliates, Vanguard's capital markets model) consistently shows that valuation gaps of this magnitude do predict long-run return differentials. You cannot dismiss this.

Demographic momentum (ex-China). India, Indonesia, Vietnam, and parts of Africa have favorable working-age population trajectories. The commodity demand from energy transition (copper, lithium, rare earths) is concentrated in EM countries. These are genuine structural tailwinds.

Mean reversion pressure. A decade of underperformance creates statistical—though not guaranteed—pressure toward reversion. The question is whether the structural factors that drove underperformance persist or resolve.

Tailwinds Facing US Small-Cap Value

Factor premium evidence. The value premium (~3–5% historical annual excess return) and size premium (~1–2%) are among the most academically validated anomalies in finance. Crucially, after a decade of underperformance relative to large-cap growth, these factors may be more likely to reassert, not less—investor abandonment of a factor is often precisely when it rebounds.

Domestic fiscal tailwinds. The IRA, CHIPS Act, and reshoring trends disproportionately benefit small-cap industrials, materials, and regional manufacturers. This is a policy-driven tailwind that doesn't depend on global growth.

Rate environment. As rates normalize from their peak, small-cap value companies—particularly regional banks, insurers, and capital-intensive industrials—often benefit from steepening yield curves. Many of these companies were actually disadvantaged by the ZIRP era.

Regulatory and legal clarity. Rule of law, property rights, and contract enforcement are substantially more reliable in the US. This doesn't appear in standard valuation comparisons but represents genuine risk reduction that should command a premium. The contrast with arbitrary regulatory crackdowns in China is stark.

Dollar denomination. Eliminates currency risk entirely for USD-based investors—one significant volatility source removed.

---

Forward-Looking Risk-Adjusted Return Estimates

Rather than false precision, here's a scenario-weighted framework:

Probability-weighted expected returns:

• EM ETFs: ~5.5–7% nominal
• US Small-Cap Value: ~6.5–9% nominal

Estimated Sharpe ratios (assuming 3–3.5% risk-free rate over horizon):

US small-cap value maintains a meaningful Sharpe advantage, driven by better downside protection, higher factor-based return expectations, and lower volatility from removed currency risk.

---

Resolving the Key Contradiction: "EM is Cheap" vs. "EM Has Low Sharpe"

Both claims are simultaneously true, and understanding why is critical. EM is cheap on valuation metrics. Low valuations historically do predict better long-run returns. But:

1. Cheap can get cheaper. Structural problems in China could sustain discount valuations for years before any reversion.
2. Valuation-predicted returns are gross returns. After adjusting for higher volatility, political risk (which isn't in the price model), and currency drag, the risk-adjusted improvement shrinks substantially.
3. The 10-year horizon matters. Valuation signals work best over 7–15 years, so EM's cheapness is a genuine argument for a patient investor—but the uncertainty range around that expected return is enormous.

The synthesis: EM's cheap valuations create a plausible case for higher absolute returns, but the excess risk means the Sharpe advantage still likely belongs to US SCV. This is not a contradiction—it's exactly what risk-adjusted thinking is for.

---

The Ex-China Solution: Resolving the EM Dilemma

The most intellectually honest resolution to the EM debate is recognizing that broad EM indices are a poorly specified product for forward-looking analysis. If the China thesis is structurally impaired, you can access EM's genuine growth story through ex-China ETFs (EMXC, AVEM). Removing 25–30% of the index that carries the highest geopolitical tail risk, regulatory unpredictability, and structural demographic headwinds meaningfully improves the expected Sharpe of any EM allocation.

India, Indonesia, Vietnam, and Mexico deserve distinct analysis from China—lumping them together in a single index weight obscures more than it reveals.

---

Practical Synthesis: Where to Land

For a risk-adjusted return focus over 10 years, US small-cap value has the better expected Sharpe ratio. This conclusion holds across most reasonable scenario weightings and is supported by factor evidence, domestic fiscal tailwinds, regulatory clarity, and currency stability.

However, abandoning EM entirely is not the intellectually defensible position. The valuation gap is too large to ignore, the correlation benefit (~0.65–0.70) provides genuine diversification, and if the dollar weakens materially, EM could be the decade's outperformer in absolute terms.

A defensible portfolio approach for a risk-tolerant long-horizon investor:

• Core domestic equity: 55–65%
• US Small-Cap Value tilt (AVUV, DFSV, or similar factor-tilted funds): 20–25%
• EM allocation: 15–20%, with strong consideration for ex-China weighting
• Reassess China position explicitly rather than accepting index weight passively

Key triggers that would shift this analysis toward EM:

• Sustained USD weakening (>15% DXY decline)
• China credibly resolving property sector issues with meaningful stimulus
• Fed cutting more aggressively than expected
• Evidence that value factor premiums are compressing in the US

Key triggers that would reinforce the SCV case:

• Continued US fiscal expansion in manufacturing/infrastructure
• Fed maintaining "higher for longer" (crushes EM currency further)
• Additional China regulatory surprises

---

Bottom Line

US small-cap value funds present a modestly to meaningfully better risk-adjusted return profile under current macroeconomic conditions, primarily due to factor premium evidence, domestic policy tailwinds, regulatory reliability, and lower effective volatility. The expected Sharpe advantage is roughly 0.15–0.25 Sharpe units—meaningful but not so overwhelming that a thoughtful investor should ignore EM entirely.

The single most important variable in this entire analysis is your position on China. If you're skeptical of China's near-term prospects, shift EM exposure toward ex-China products rather than abandoning developing market exposure entirely. That move likely improves EM's risk-adjusted profile enough to make a meaningful allocation genuinely competitive with US SCV—and preserves the diversification benefit both asset classes provide.

This analysis reflects publicly available information and general investment frameworks. It is not personalized financial advice. Consult a qualified advisor before making investment decisions.